Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2025 · 10-Q
Revenue$821.50M$821.50M+6.6% vs Q3 2024 Net Income-$22.70M-$22.70MN/M vs Q3 2024 EPS Diluted-$0.18-$0.18N/M vs Q3 2024 Operating Income$105,700,000+73.6% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$63,800,000+41.8% Margins · derivedOperating margin12.9%+5.0 pt vs Q3 2024
Net margin-2.8%+1.4 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d after period end